Skip to main content
. 2022 May 26;1(2):100029. doi: 10.1016/j.jacadv.2022.100029

Table 1.

Study Population

MBTTS (n = 148) RVPAS (n = 158) P Value
Hospitals 0.69
 1 3% (5) 7% (11)
 2 9% (14) 12% (19)
 3 9% (13) 8% (12)
 4 12% (18) 11% (17)
 5 9% (14) 12% (18)
 6 30% (44) 27% (42)
 7 15% (22) 13% (20)
 8 1% (2) 0% (0)
 9 11% (16) 10% (15)
Female sex 39% (57) 37% (57) 0.81
Race 0.47
 White 80% (118) 81% (124)
 Black 17% (25) 14% (21)
 Other/missing 3% (5) 6% (9)
Hispanic ethnicity 20% (29) 28% (43) 0.10
Birth weight (kg) 3.1 ± 0.6 3.0 ± 0.5 0.08
Gestational age <38 wk (%) 30% (45) 31% (43) 1.00
Age at Norwood (d) 5.1 ± 3.3 5.1 ± 3.3 0.94
Payer 0.90
 Private 41% (60) 40% (61)
 Public 39% (58) 42% (64)
 Other 20% (30) 19% (29)
Primary diagnosis 0.44
 HLHS 87% (129) 86% (132)
 Critical AS 1% (1) 0% (0)
 Single RV with outflow tract obstruction 5% (8) 3% (5)
 RV dominant AV canal 5% (7) 6% (10)
 Other 2% (3) 5% (7)
Prenatal diagnosis 74% (110) 82% (126) 0.13
Aortic atresia 66% (97) 66% (102) 0.90
Pulmonary vein stenosis 3% (5) 4% (6) 1.00
Associated diagnosis 30% (44) 25% (38) 0.36

Values are % (n).

AS = aortic stenosis; AV = atrioventricular; HLHS = hypoplastic left heart syndrome; MBTTS = modified Blalock-Taussig-Thomas shunts; RVPAS = right ventricle to pulmonary artery shunts.